ÂÜÀòÂÒÂ×

Declan Kinahan is an experienced professional in health technology assessment, currently serving as the European Health Technology Assessment Manager at Otsuka Pharmaceutical Companies Europe since May 2022. Previously, Kinahan held roles such as Senior Consultant at Decision Resources Group, Market Access Manager at MAP BioPharma Limited, and Health Technology Assessment Manager at AbbVie. Kinahan's expertise includes developing HTA strategies, managing cross-functional collaboration, and conducting comprehensive economic analysis for health technologies. Educational qualifications include a Bachelor of Commerce in Economics from University of Galway and a Master of Science in Health Economics from University College Cork.